Company intelligence / Profile preview

OptiScan Biomedical

Hayward, California, United Statesascensionventures.org ↗

Ownership: Private
Employees: ~31
Development stage: Preclinical

Overview

The company’s lead product, the OptiScanner series (notably the OptiScanner 5000 and CE-marked OptiScanner 7000), provides automated bedside glucose monitoring with updates every fifteen minutes using spectroscopy directly from plasma. Peer-reviewed studies show improved glycemic control and trending data compared to manual methods. The company has expanded its platform to monitor additional analytes such as lactate and ScvO₂ to support early sepsis detection and overall critical care management.

Therapeutic areas: Metabolic DisordersEndocrinologyInfectious Diseases
Modalities: Device (automated blood monitoring system)Diagnostic device (spectroscopy-based plasma analysis)
Industry: Physiological Monitoring

Partnerships

Ascension Ventures investor relationship noted but no major pharma partnerships disclosed.

Beyond the preview

Go deeper on OptiScan Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OptiScan Biomedical.

Explore the full profile